Trial Profile
A Phase I/II Study of Hydroxychloroquine and Itraconazole as Therapy for Men With Androgen Normalised Prostate Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 24 Nov 2023
Price :
$35
*
At a glance
- Drugs Hydroxychloroquine (Primary) ; Itraconazole (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions
- Acronyms HITMAN-PC
- 20 Nov 2023 Status changed from active, no longer recruiting to completed.
- 16 Dec 2022 Status changed from recruiting to active, no longer recruiting.
- 03 May 2022 Planned End Date changed from 30 Mar 2023 to 30 Jul 2024.